Repligen Corp
NASDAQ:RGEN

  • LAST PRICE
    124.7300
  • TODAY'S CHANGE (%)
    -17.7000 (-12.4272%)
  • Bid / Lots
    125.0000/ 1
  • Ask / Lots
    145.0000/ 1
  • Open / Previous Close
    140.8700 / 142.4300
  • Day Range
    121.5200
    141.1700
  • 52 Week Range
    113.5000
    211.1300
  • Volume
    1,932,923

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
RGEN
Repligen Corp
7.0B
-405.1x
+15.08%
GKOS
Glaukos Corp
7.6B
-46.7x
---
STVN
Stevanato Group SpA
5.8B
42.2x
---
MMSI
Merit Medical Systems Inc
5.9B
49.9x
+14.05%
INSP
Inspire Medical Systems Inc
5.2B
158.7x
---
LNTH
Lantheus Holdings Inc
5.3B
12.8x
+35.30%
As of 2024-11-17

Company Information

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.

Contact Information

Headquarters
BUILDING 1, SUITE 100, 41 SEYON STREETWALTHAM, MA, United States 02453
Phone
781-449-9560
Fax
302-655-5049

Executives

Executive Chairman of the Board
Tony Hunt
President, Chief Executive Officer
Olivier Loeillot
Chief Financial Officer
Jason Garland
Chief Operating Officer
James Bylund
Senior Vice President - Filtration and Chromatography
Christine Gebski

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$7.0B
Revenue (TTM)
$622.6M
Shares Outstanding
56.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.94
EPS
$-0.31
Book Value
$35.35
P/E Ratio
-405.1x
Price/Sales (TTM)
11.2
Price/Cash Flow (TTM)
203.6x
Operating Margin
-1.96%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.